Skip to main content
. 2020 Dec 14;20:182. doi: 10.1186/s12902-020-00659-5

Table 2.

Clinical features of mild, moderate and severe groups of DKA on admission

Variables Mild group Moderate group Severe group
Number of patients 25 21 19
Age (years) 59.0 ± 18.4 53.2 ± 14.9 46.3 ± 13.0 b
Gender (male: female) 11:14 14:7 13:6
History of DM (years) 7.62 ± 6.93 8.32 ± 5.93 4.77 ± 5.99
Hospital stay (days) 9.89 ± 5.86 11.14 ± 4.86 13.00 ± 4.40 b
Expenses (Yuan) 9958.0 ± 7267.5 11,085.9 ± 7952.6 12,336.4 ± 8080.6
RBG (mmol/L) 20.01 ± 5.32 20.45 ± 5.81 21.67 ± 7.20
HbA1c(%) 11.63 ± 2.66 11.47 ± 2.65 11.69 ± 2.52
Fasting C-peptide (ng/mL) 1.00 ± 0.89 0.39 ± 0.35 a 0.32 ± 0.31bb
Arterial PH 7.30 ± 0.02 7.21 ± 0.05 aa 7.11 ± 0.09 bb,cc
SB (mmol/L) 17.46 ± 2.23 12.37 ± 1.47 aa 7.20 ± 2.15 bb,cc
EPO (mOsm/L) 307.20 ± 14.21 310.66 ± 16.65 319.03 ± 11.72
Na (mmol/L) 135.84 ± 4.66 136.85 ± 6.08 135.05 ± 6.54
BUN (mmol/L) 7.65 ± 6.15 8.29 ± 4.86 8.09 ± 4.44
Cr (umol/L) 77.00 ± 25.05 102.52 ± 76.06 123.74 ± 83.72 b
CRP (mg/L) 10.50 (7.0–28.50) 67.19 ± 52.06 91.60 ± 64.79 bb

Note: mild group vs moderate group, a P < 0.05, aa P < 0.01

mild group vs severe group, b P < 0.05, bb P < 0.01

moderate group vs severe group, cc P < 0.01